Optic neuritis is an inflammation of the optic nerve.
It can cause severe pressure, pain and headaches and may result in the destruction of the protective myelin sheath that covers the optic nerve. These conditions are usually the result of an autoimmune reaction or disorder in which the body mistakes its own oligodendrocytes for a pathogen and essentially attacks them.
Any time the myelin sheath has been destroyed or severely compromised, the nerve is susceptible to direct damage. Optic neuropathy is a general term used to describe any conditions that result in damage to the optic nerve. Symptoms would include blurred vision in only one eye, double vision, difficulty in coordination and fatigue. Benign tumors can also form in the optic nerve sheath and cause these side effects. Tumor growth may compress the optic nerve and cause loss of vision in the affected eye.
Research has been conducted for many years to develop techniques for detecting these issues early on and repairing the myelin sheaths. One option to patients might be the surgical implanting of oligodendrocyte precursor cells. Other times, the condition is so progressed or acute that there may not be a cure, only medications and treatments to deal with pain or slow the condition's progress.
Classic clinical findings of multiple sclerosis are optic neuritis, paresthesias, INO and bladder symptoms.
The percentage of patients with an attack of optic neuritis and no prior attack that will go on to develop MS ranges from 17–87%, depending on the series 1).
Nitrofurantoin (Macrodantin®): may cause optic neuritis.
Papilledema may appear similar to optic neuritis on funduscopy, but the latter is usually associated with more severe visual loss and tenderness to eye pressure over the eye.
Early bevacizumab therapy in steroid refractory radiation induced optic neuritis (RION) shows gratifying results 2).
### Associated Conditions: - Multiple Sclerosis (MS): Optic neuritis is often the first symptom of MS, and up to 50% of people with optic neuritis will develop MS. - Neuromyelitis Optica: A condition that also causes inflammation in the optic nerves and spinal cord.
Optic neuritis can present similarly to other conditions affecting vision or the optic nerve. To ensure an accurate diagnosis, physicians consider several conditions in the differential diagnosis of optic neuritis. These conditions may have overlapping symptoms, such as visual loss, optic nerve inflammation, or pain. Below are key conditions that are typically included in the differential diagnosis:
### 1. Neuromyelitis Optica Spectrum Disorder (NMOSD)
### 2. Multiple Sclerosis (MS)
### 3. Ischemic Optic Neuropathy (ION)
### 4. Compressive Optic Neuropathy
### 5. Leber's Hereditary Optic Neuropathy (LHON)
### 6. Sarcoidosis-Associated Optic Neuropathy
### 7. Infectious Optic Neuritis
### 8. Toxic or Nutritional Optic Neuropathy
### 9. Autoimmune-Related Optic Neuropathy
### 10. Central Retinal Artery Occlusion (CRAO)
### 11. Acute Disseminated Encephalomyelitis (ADEM)
### 12. Paraneoplastic Optic Neuropathy
—
### Diagnostic Tools to Differentiate Causes: 1. MRI: To assess optic nerve and brain lesions. 2. Blood Tests: For autoimmune markers, infections, and toxins. 3. CSF Analysis: In cases of suspected autoimmune or infectious causes. 4. Visual Field Testing: To map visual deficits. 5. Genetic Testing: For hereditary optic neuropathies like LHON. 6. Biopsy: Temporal artery biopsy in suspected giant cell arteritis.
Correct diagnosis involves ruling out these differentials through clinical assessment, imaging, and lab tests.
- Corticosteroids: High-dose intravenous steroids may be used to reduce inflammation and speed up recovery. - Plasma Exchange: In severe cases, plasma exchange may be used if steroids are ineffective.
Early diagnosis and treatment are important to prevent long-term vision problems.
In a patient-physician perspective article, Braithwaite et al. shared the story of a patient affected by an autoimmune disease that attacks the nerves connecting the eyes and the brain and reflects back physicians’ perspectives on the disease and the patient’s experience of it. In a compelling account, we gain some understanding of what it might be like to live with the fear of unpredictable episodes of sudden, recurrent sight loss and the important impacts that this has on a patient’s life and mental wellbeing. We recognize that the outcome metrics that physicians usually focus on, such as measurement of vision and imaging of the optic nerve, do not fully capture the outcomes that most matter to the patient. We explore patient-reported outcome measures that go some way towards bridging this gap. Finally, we consider the technological advances that will make more comprehensive capture of the patient experience reality in future clinical practice and research, supporting both patients and physicians to optimize shared care 3).